Japan’s Nagoya University Establish Bio Venture Company To Develop Arteriosclerosis Drugs
This article was originally published in PharmAsia News
Executive Summary
Nagoya City University established the venture company Hyks Laboratories to develop drugs to treat and prevent arteriosclerosis. Utilizing funds from the Japan Science and Technology Agency, the university's school of medicine has been focusing on research and development of a drug to increase blood's high-density lipoproteins count, Based on the research results, the company also plans to partner with pharmaceutical companies to conduct basic research on HDL functions. Cerebral vascular diseases account for one third of the total deaths in Japan and prevention and treatment have become a major topic for medical researchers and pharmaceutical companies. (Click here for more - Japanese language